Object. The choice of approach for surgical removal of large acoustic neuromas is still controversial. The authors reviewed the results in a series of patients who underwent removal of large tumors via the translabyrinthine approach.
of the cerebrospinal fluid (CSF) pathway, with resultant hydrocephalus.
The goal of treatment of acoustic neuromas is to maximize total tumor removal while minimizing the risk of complications. Surgery is the treatment of choice for most patients; it has a long history of success.
There are three basic surgical approaches currently used for removal of acoustic neuromas. The middle fossa exposure allows a view of the lateral end of the IAC and, thus, total removal of smaller tumors with an excellent chance for preservation of hearing. The suboccipital exposure, which is used by many surgeons to treat all sizes of tumors, does not enter the inner ear unless drilling violates the posterior semicircular canal; however, this canal prevents viewing of the lateral end of the IAC. The translabyrinthine exposure always destroys remaining hearing, if any. However, a clean dissection of tumor from the facial nerve in the IAC with little chance of recurrence and excellent success in anatomically preserving the facial nerve, coupled with the ready ability to perform a direct seventh-seventh nerve attachment when necessary, are all appealing features of the translabyrinthine technique. [40] In addition, the anterior brainstem region can be viewed and retraction of the cerebellum is minimized when this approach is used.
When selecting a surgical approach to acoustic neuromas, the size of the tumor is a primary consideration. In cases of small tumors (< 2 cm), preservation of serviceable hearing is a realistic goal, and the primary aims of total tumor removal and normal facial nerve function are still achieved. [21] However, in cases of large tumors, it is generally accepted that hearing preservation is extremely unlikely and should not influence the choice of the surgical approach. [3] Many surgeons consider tumors measuring 4 cm or more to be too large to remove via the translabyrinthine approach because of the perceived limitations of viewing and operating space within the cerebellopontine angle (CPA). However, one of the authors (W.E.H.) has had experience with more than 6000 CPA tumors and has never encountered an acoustic neuroma that was "too large" to remove via a translabyrinthine approach. This approach has shown the advantage of early identification of the distal facial nerve in the IAC and the ability to remove the entire tumor with little cerebellar retraction. Because the key goals when dealing with removal of large acoustic neuromas are total tumor removal and facial nerve preservation, the translabyrinthine exposure, when properly performed, has an important advantage among the available approaches. [40] We have used the translabyrinthine approach to remove large tumors in 190 patients during the past 5 years. In this study, we reviewed outcomes in these consecutive cases, including completeness of tumor removal, postoperative facial nerve function, and postoperative complications.
CLINICAL MATERIAL AND METHODS

Patients and Symptoms
From 1990 through 1995, 190 patients with large acoustic neuromas (>/= 3 cm in largest diameter, not including tumor within the IAC) underwent primary or secondary removal of their tumor via the translabyrinthine approach. Data for these cases were retrieved from a computer database at the House Ear Institute, which contained preoperative, surgical, and postoperative data on a series of 1660 patients with acoustic tumors, 900 of whom were surgically treated between 1990 and 1995.
There were 89 males and 101 females with a mean age at the time of surgery of 46.1 ± 15.6 years (standard deviation [SD]), with a range from 12.7 to 82.6 years. The side of the lesion was equally divided between right and left. Diagnosis was confirmed by magnetic resonance imaging in most cases (97%) and computerized tomography scanning in a few others (2.6%). The sizes of the tumors ranged from 3 to 7 cm, with a mean of 3.6 ± 0.8 cm (SD); 36% of the tumors were 4 cm or larger. The patients' clinical presentations included hearing loss, dizziness, tinnitus, headache, paresthesia, and other symptoms (Table 1) . All but 12 patients (6.3%) had hearing loss, with a mean preoperative pure-tone average threshold of 59.6 dB and a mean speech discrimination score of 49%. More than half of the patients had preoperative hearing categorized as Class C (5.3%) or D (47.9%) according to the American Academy of Otolaryngology, Head and Neck Surgery (AAO-HNS) hearing classification system, [8] indicating a poor pure-tone average threshold (> 50 dB) and/or poor speech discrimination (< 50%).
Frequent preoperative cranial nerve deficits included ipsilateral loss of the corneal reflex and facial paresthesia (fifth cranial nerve deficits). Facial nerve weakness (seventh cranial nerve deficit), decreased gag reflex (ninth cranial nerve deficit), and vagal paresis (10th cranial nerve deficit) were present in only a few patients. Dysmetria or cerebellar ataxia, nystagmus, and papilledema were also present in some patients ( Table 2) .
Surgical Technique
All operations were performed by both a neurosurgeon and neurotological surgeon. Of the 190 surgical procedures, 178 were primary surgeries and 12 were revisions. All were performed via the translabyrinthine approach and the surgical technique was that described by House with minor modifications. [6, 19] The facial nerve is identified in the lateral IAC at the transverse crest, and the superior and inferior vestibular and cochlear nerves are disarticulated from the lateral canal. The nerves and tumor are dissected in a lateral-to-medial direction with lateral dissection of the facial nerve and intermittent tumor debulking. Frequent facial nerve identification and stimulation for monitoring response is performed throughout the procedure. Once the entire tumor is removed, the dura is approximated with sutures and abdominal fat is packed into the dural opening for a watertight closure. The eustachian tube and antrum are also packed with muscle, fat, or Surgicel.
Because most experienced neurosurgeons are capable of resecting these tumors by using the microsurgical technique, it cannot be overemphasized that the key to this approach, which can be provided by an experienced neurotologist, is having the necessary wide exposure obtained by removing bone superiorly and posteriorly. In the case of a high jugular bulb, it is necessary to skeletonize it thoroughly to gain inferior exposure. Bone is removed anterior to the high jugular bulb until the entire inferior lip of the IAC is removed. To avoid injury to the ninth cranial nerve, care is taken not to proceed anterior and inferior to the cochlear aqueduct. The bulb is also skeletonized posteriorly and bone is removed in the area of the sigmoid sulcus so that inferior exposure is obtained posterior to the jugular bulb. Properly skeletonized, a high jugular bulb is not particularly restrictive in the translabyrinthine approach.
Intraoperative Monitoring
Intraoperative facial nerve monitoring is routinely used. An audiologist trained in intraoperative monitoring is present in the operating room to provide technical support and to clarify questions concerning responses. These procedures have been described in detail elsewhere. [29] 
Outcome Measures and Statistical Analysis
Outcome measures included completeness of tumor removal (total, planned partial, or intraoperatively elected partial), facial nerve function (House-Brackmann facial nerve grade [18] ), and complications (including CSF leakage, meningitis, cerebellar ataxia, and central nervous system signs). Facial nerve function was assessed immediately postoperatively, at the time of discharge from the hospital, at the postoperative visit (1-4 weeks), and at follow-up review, which usually took place 1 year after surgery. The follow-up assessment was obtained by examination (50%) or by means of a questionnaire (50%) routinely sent to patients approximately 1 year after acoustic tumor removal. [2] For some analyses, facial nerve function was categorized as excellent (Grades I/II), intermediate (Grade III or IV), or poor (Grade V or VI); acceptable function was considered to include Grades I through IV.
Data analysis was performed using a computer statistical program (SPSS for Windows; SPSS Inc., Chicago, IL). Descriptive statistics were produced for all variables (frequency and percentage for categorical and ordinal variables; mean and SD for continuous variables). In addition, cross-tabulation tables and a chi-square statistic, when appropriate, were used to evaluate the possibility of bias concerning the patients in whom follow-up data were available. For these analyses, the criterion for statistical significance was set at a probability value of 0.05 or less in a two-tailed test.
RESULTS
The average operative time for the 190 procedures was 4.4 ± 1.1 hours and ranged from 2.6 to 8.6 hours. The average hospital stay was 7.9 ± 3.7 days with a minimum stay of 4 days and a maximum stay of 38 days. Eighty-seven percent of the patients had a hospital stay of 10 days or less. Mean blood loss during surgery was 431 ± 259 ml, and blood transfusion was necessary in 22.7% of patients, with 37 patients receiving 1 U of autologous blood and six patients requiring more than 1 U of blood. There were no deaths.
Completeness of Tumor Removal
The tumor was identified as arising from the superior vestibular nerve in 61 patients (32.1%) and the inferior vestibular nerve in 24 patients (12.6%); the other tumors were either combined or of undetermined origin. Removal of tumor was considered total in 183 cases (96.3%). Tumor removal was planned as partial in four patients and elected in three for reasons such as patient's age or invasion of the facial or other nerves (in one case, invasion of the sixth cranial nerve). In these patients, only microscopic deposits were left on the seventh nerve. It was not known whether these deposits were viable residual tumor or simply a reaction on the seventh nerve secondary to the tumor.
Facial Nerve Outcome
Preoperatively, facial nerve function was normal (Grade I) in the majority of patients (95.3%), with only two patients exhibiting poor function (Grade V or VI). The facial nerve was preserved anatomically intact in 178 cases (93.7%), although the tumor was adherent to the facial nerve in 64% and severely so in 16%. Of the 12 cases in which the facial nerve was divided, six nerves were severed intentionally for either tumor removal or to improve existing poor function by anatomical repair. Repair was performed by primary nerve attachment (seven cases) or use of a cable graft (three cases).
Facial nerve function at each of the four assessment intervals is shown in Table 3 . The mean time from surgery to the postoperative visit was 2.4 ± 3 weeks (SD), with a range from slightly less than 1 week to 6 months and a median of 1.8 weeks. The mean time to follow-up assessment was 12.6 ± 6.8 months (SD), with a median of 13.1 months.
In the immediate postoperative period, 38.6% of patients had normal facial nerve function (Grade I) and 55% had excellent function (Grades I-II). Although the percentage of patients with poor results (Grade V or VI) increased from 23.3% in the immediate postoperative period to 51.6% at time of discharge, results
Because long-term follow-up data were available in only half of the patients, we assessed the likelihood of any bias in long-term facial nerve results. It has been previously shown that the House-Brackmann facial nerve grade in the immediate postoperative period is highly prognostic of long-term results, [1] and this appears to be the case in this study as well (Table 3) . Of those patients who had excellent facial function in the immediate postoperative period, 76% also had excellent function at follow up and 98.2% had an acceptable result. Of those with an excellent facial nerve grade at the postoperative visit, all but one also had Grade I or II at follow up; in all categories, all but one had a follow-up result that was the same or better than the postoperative result. We also compared those patients who had follow-up assessment and those who did not to assure that they did not represent different subgroups of patients in whom results might be expected to differ. There were no significant differences in mean patient age at surgery, operative time, or size of tumor. More important, there were no significant differences between the two groups with respect to early facial nerve function. For example, at the immediate postoperative examination, 23.2% of the patients in whom follow-up assessment was performed and 23.4% of the patients without follow up had poor facial nerve function. At the postoperative visit, 39.5% of the patients who had follow up and 35.3% of those without follow up had excellent function.
We also evaluated whether there were differences between those patients whose follow-up facial nerve grade was determined by examination and those whose function was determined by questionnaire. Those evaluated by examination had poorer results (39.6% excellent and 22.9% poor) than those evaluated by questionnaire (65.2% excellent and 15.2% poor) (chi-square = 6.3, p </= 0.043); however, the former group also had a significantly shorter follow-up time (mean follow up 10.7 ± 7 [SD] compared with 15 ± 5.7 [SD] months) (t = 3.38, p </= 0.001). This appears to be due to the patients' early function results and not the method of follow up. Of those patients with poor immediate postoperative function, 72.7% were followed by examination, whereas 43.9% of those patients with excellent results were examined (chi-square = 5.88, p </= 0.053).
Thus, although long-term follow up of facial nerve function was not available for review in all patients and assessments were performed by two different methods (examination and questionnaire), there is good reason to believe that the 95 patients who underwent follow-up review are representative of the overall sample of 190 patients.
As expected, facial nerve outcome was related to tumor size (Spearman p = 0.33, p </= 0.001), with poor results (Grade V or VI) in 50% of patients with tumors larger than 4 cm compared with 27.8% of those with tumors measuring 4 cm, and less than 10% of those with tumors smaller than 4 cm.
Postoperative Complications
A summary of postoperative complications is shown in Table 4 . The most common complication was CSF leakage, either from the wound or rhinorrhea. Of 190 procedures, 27 patients had a CSF leak, only two of whom required surgical repair and five of whom required lumbar drainage. Seven patients developed meningitis, four of whom also had a CSF leak. All CSF leaks were resolved with proper management.
In addition to the risk to the seventh and eighth cranial nerves, other cranial nerve deficits may occur in patients with larger tumors. In this series, eight patients experienced glossopharyngeal dysfunction (ninth cranial nerve deficit), seven had vagal paresis and partial swallowing difficulty (10th cranial nerve deficit), and seven showed temporary diplopia secondary to either sixth or fourth cranial nerve palsies. To our knowledge, all palsies of the fourth, sixth, ninth, and 10th cranial nerves were transient.
Cerebellar ataxia was a relatively common finding (12.6%) in this group. However, 23 of these 24 patients had preoperative ataxia. Although some patients had immediate improvement in ataxia after tumor removal, most were initially worse before their symptoms gradually resolved. Other complications occurring in small numbers of patients included pneumonia, acute depression, cystitis, dysmetria, and syncope. Fourteen patients (7.4%) had to be rehospitalized: three for CSF leak, one for meningitis, and 10 for other reasons such as pneumonia.
Because, in our experience, we found that postoperative headache is uncommon when the translabyrinthine approach is used, this particular "complication" is not formally included on our database data collection form, and we cannot provide quantitative information regarding its occurrence. Size of the tumor was not significantly related to complications.
DISCUSSION
Debate has continued for 20 years regarding the approach to be used for extirpation of CPA tumors, specifically acoustic neuromas. Maddox [24] reported his surgical experience in 106 consecutive cases via his lateral approach, which combined the translabyrinthine and retrosigmoid routes. He accomplished facial nerve preservation in 88% of the cases and concluded that the posterior suboccipital approach to acoustic tumors should be rejected. A decade later, Glasscock, et al., [15] reported that in 616 cases preservation of the facial nerve was directly related to the size of the tumor. They used four different approaches, choosing each approach on the basis of tumor size and auditory reserve in the involved ear; the translabyrinthine approach was used most often and a combined translabyrinthine-suboccipital approach was used for tumors larger than 3 cm. Mangham [25] examined the surgical complication rate resulting from both the translabyrinthine and suboccipital approaches for acoustic neuroma surgery and found no significant differences. However, he presented a decision tree by which one could systematically determine surgical approach based on tumor size and the desire for hearing conservation. For cases of large tumors (> 2.5 cm), the suboccipital approach would be used; for cases of small tumors (< 2.5 cm) and no hearing conservation, the translabyrinthine approach; for hearing conservation in cases of very small tumors (</= 1 cm), the middle fossa approach; and for hearing conservation in cases of slightly larger tumors (> 1-2.5 cm), the suboccipital approach. Similarly, Thomsen and colleagues [37] discussed the choice of approach for acoustic neuromas and outlined the Copenhagen treatment algorithm, including use of the translabyrinthine approach for tumors larger than 2.5 cm.
Because of the perceived limitations of viewing and operating space within the CPA, many surgeons do not recommend the translabyrinthine approach for treating large tumors. However, with skilled wide temporal bone dissection and the improved illumination and magnification afforded by the operating microscope, the translabyrinthine approach has been shown to be advantageous for removal of acoustic neuromas and other CPA tumors. [6] Advantages of the approach include: 1) identification of the facial nerve early in the procedure via a constant bony landmark; 2) increased preservation of the anatomical and functional integrity of the facial nerve; 3) minimal, if any, cerebellar and brainstem retraction; 4) shorter distance between the surface and the neoplasm; 5) avoidance of the sitting position for the patient; 6) lower incidence of postoperative headaches than the suboccipital approach; 7) easy access to the tumor bed for management of postoperative complications; and 8) improved surgeon comfort. [11] Using the surgical techniques we describe facilitates complete medial dissection for exposure of the CPA. [13] We use the translabyrinthine approach in all patients without useful hearing, regardless of tumor size. The skilled and experienced neurotologist provides extensive presigmoid, translabyrinthine temporal bone dissection, enabling the neurosurgeon to remove any size tumor via this approach.
We also find that the added breadth of experience, background, and skills inherent in a combined multidisciplinary approach including a neurosurgeon and neurotologist lead to improved outcomes. Whittaker [39] recently reminded us of the "House dictum" that the otologist and the neurosurgeon should be cosurgeons, each capable of performing the entire operation. He further indicated that when surgery is the treatment choice, he always advises the translabyrinthine approach unless hearing preservation is to be attempted. In that situation, he prefers the middle fossa approach to a posterior fossa approach because he believes that the retrosigmoid operation leaves tumor behind in the lateral aspect of the IAC and, at least in his hands, places the facial nerve in greater jeopardy.
Facial Nerve Preservation
Facial nerve preservation has always been considered to be a primary concern in acoustic neuroma surgery, particularly in patients with a large tumor, in whom the nerve is usually adherent to the surface of the tumor. Table 5 summarizes facial nerve anatomical preservation results in large tumors from a number of studies. Direct comparisons between studies should be made only with extreme caution, because the number of cases, experience of surgeons over the course of the reported series, methods used to measure tumor size, use of intraoperative monitoring, and criteria for choosing the approach are not necessarily equivalent across studies. In general, results indicate that facial nerve preservation rates when using the translabyrinthine approach for large tumors are high (47-97%). Anatomical preservation of the facial nerve was achieved using the translabyrinthine approach in more than 90% of recent cases at our institution (present data and those of Briggs, et al. [3] ), with even early results as high as 88%. [20] Facial nerve anatomical preservation rates reported for the suboccipital approach range from 65 to 89%.
However, anatomical preservation of the facial nerve is not equivalent to functional preservation. For acoustic neuromas, the larger the tumor size, the more difficult it is to maintain the integrity of the facial nerve. [31] Functional preservation results from our and other studies of large tumors are summarized in Table 6 . Criteria for preservation of facial nerve function may differ from one study to another. Where possible, we have presented the percentage of patients achieving a House-Brackmann Grade IV or better postoperative function, or its equivalent, for "large" tumors. However, we found that much of the literature was vague or confusing in the presentation of results. For example, tumor-size categories were often not clearly defined and/or the number of cases in each category was not presented. Frequently, results were not reported for size categories. In addition, procedures performed before and after the advent of facial nerve monitoring were often combined, but not always. Thus, we warn again that comparisons between listed studies must be made only with caution. Reported rates of functional preservation when using the translabyrinthine approach vary greatly, ranging from 20 to 82%, with the majority of authors reporting rates above 60% and as high as 82%. Similarly, published results for the suboccipital approach range from 56 to 88%.
Hearing Preservation
Preservation of hearing is another concern in acoustic neuroma surgery. [12, 35] Some authors have reported attempts at auditory preservation without regard to preoperative hearing levels or tumor size. Over a decade ago Clemis [7] suggested that hearing preservation should be attempted only when hearing is excellent (defined as a speech reception threshold < 30 dB and discrimination > 80%) or when the tumor extends less than 20 mm outside the IAC. Glasscock and associates [14] argued that successful preservation of hearing in the presence of a normal contralateral ear should be defined as a speech discrimination score of greater than 70% and that any lesser result is a failure because: 1) balance cannot be achieved between the good ear and the impaired ear; 2) directional hearing is impossible; and 3) hearing in noisy environments is problematic. For large acoustic neuromas, the chance of retaining useful hearing is small. [3] Ebersold, et al., [10] reported no postoperative hearing in any of their patients with tumors measuring more than 4 cm and measurable hearing in only 4% of all patients with tumors larger than 2 cm, using the retrosigmoid approach for tumor removal. After reviewing the literature, Whittaker and Luetje [40] concluded that only 7 to 9% of patients with acoustic neuroma--including all tumor sizes--are likely to have preserved hearing. They recommend hearing-preservation approaches only when the tumor is less than 2 cm in diameter and the preoperative speech discrimination score is 70% or higher.
Postoperative Complications
Cerebrospinal fluid leak and meningitis are usually considered serious complications of acoustic tumor surgery. Mangham [25] found no significant differences in the incidence of CSF rhinorrhea or leak through the wound between his translabyrinthine and suboccipital groups. The rate of all CSF leaks was similar in our series (14%) to those reported by Mangham and others. [5, 15, 25, 30, 34] For example, Glasscock, et al., [15] reported a rate of 11%, whereas Bryce, et al., [4] reported 18% in patients with large tumors who underwent the translabyrinthine approach. We found no relationship between the size of the tumor and the incidence of CSF leak for tumors 3 cm or larger.
Headache, a common problem following suboccipital removal of acoustic tumors, is not a frequently reported problem in patients who undergo the translabyrinthine approach. For example, Schessel and colleagues [33] found that, although 64% of their patients in whom the suboccipital approach was used for removal of an acoustic neuroma experienced significant postoperative local discomfort and headache, in a group of patients matched for tumor size, age, and gender who had undergone translabyrinthine removal this was "notably absent." Our experience is similar.
CONCLUSIONS
A review of 190 patients who underwent large acoustic neuroma (> 3 cm) removal via the translabyrinthine approach shows good anatomical and functional preservation of the facial nerve and a high rate of total tumor removal, with an average operating time of 4 hours, minimal incidence of morbidity, and no incidence of mortality. In fact, we believe that this approach offers the best opportunity for preservation of facial nerve function and not merely anatomical preservation. Patients with large acoustic neuromas are unlikely to have any hearing preserved. Therefore, we continue to recommend use of this approach for acoustic tumors larger than 3 cm and for smaller tumors in cases in which functional hearing preservation (>/= 70% speech discrimination) is not an issue.
